| Literature DB >> 25583515 |
Ning Feng1, Sabine Huke2, Guangshuo Zhu1, Carlo G Tocchetti3, Sa Shi1, Takeshi Aiba4, Nina Kaludercic5, Donald B Hoover6, Sarah E Beck7, Joseph L Mankowski7, Gordon F Tomaselli1, Donald M Bers8, David A Kass1, Nazareno Paolocci9.
Abstract
BDNF and its associated tropomyosin-related kinase receptor B (TrkB) nurture vessels and nerves serving the heart. However, the direct effect of BDNF/TrkB signaling on the myocardium is poorly understood. Here we report that cardiac-specific TrkB knockout mice (TrkB(-/-)) display impaired cardiac contraction and relaxation, showing that BDNF/TrkB signaling acts constitutively to sustain in vivo myocardial performance. BDNF enhances normal cardiomyocyte Ca(2+) cycling, contractility, and relaxation via Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). Conversely, failing myocytes, which have increased truncated TrkB lacking tyrosine kinase activity and chronically activated CaMKII, are insensitive to BDNF. Thus, BDNF/TrkB signaling represents a previously unidentified pathway by which the peripheral nervous system directly and tonically influences myocardial function in parallel with β-adrenergic control. Deficits in this system are likely additional contributors to acute and chronic cardiac dysfunction.Entities:
Keywords: BDNF; CaMKII; TrkB receptor; cardiac contractility/relaxation; neurotrophins
Mesh:
Substances:
Year: 2015 PMID: 25583515 PMCID: PMC4330748 DOI: 10.1073/pnas.1417949112
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205